We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Therapeutic Device Reduces Disability Following Stroke

By HospiMedica International staff writers
Posted on 22 Feb 2021
Print article
Image: Low intensity electromagnetic fields can assist recovery from stroke (Photo courtesy of BrainQ)
Image: Low intensity electromagnetic fields can assist recovery from stroke (Photo courtesy of BrainQ)
Artificial intelligence (AI) powered therapy generates electromagnetic fields that enhance recovery and reduce disability caused by ischemic stroke.

The BrainQ (Jerusalem, Israel) BQ System is a cloud-connected wearable device that delivers extremely low frequency low intensity electromagnetic fields (ELF-EMF), tailored to the individual patient. By measuring several electrophysiology measures, such as electroencephalography (EEG), electromyography (EMG), and magnetoencephalography (MEG), which characterize the neural oscillatory activity, the device can deliver the neuromodulatory ELF-EMF therapy at specific frequencies to influence these oscillations and aid neurorecovery.

The BQ System extends the window of opportunity for stroke treatment from several hours during the acute phase to days and even weeks in the sub-acute phase following stroke. The effect of ELF-EMF on recovery from neurological conditions include evidences of changes in calcium signaling, which is known to influence and mediate nearly all cellular processes; proliferation, as well as differentiation, of multiple cell types (including neurogenesis of neural stem cells); peripheral nerve regeneration; effects on polar molecules, likely responsible for the development of the neural projections; and changes in plasticity-related growth factor levels in humans.

“Stroke is a debilitating condition with limited recovery options, creating a huge unmet need in the United States. Covid-19 has only made things worse by limiting patients' access to treatment facilities,” said Yotam Drechsler, CEO and co-founder of BrainQ. “We are on the verge of a new era where AI- based precision medicine will be used to treat neurodisorders, which do not have a sufficient solution to date.”

Neuroplasticity describes the ability of neural networks in the brain to change through growth and reorganization. These changes range from individual neuron pathways making new connections, to systematic adjustments like cortical remapping. Neuroplasticity was once thought to exist only during childhood, but research has shown that activity-dependent plasticity, which can manifest even in adulthood, can have significant implications for recovery from brain damage.

Related Links:
BrainQ

Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Anesthesia Workstation
X40

Print article

Channels

Critical Care

view channel
Image: The stretchable microneedle electrode arrays (Photo courtesy of Zhao Research Group)

Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment

The field of personalized medicine is transforming rapidly, with advancements like wearable devices and home testing kits making it increasingly easy to monitor a wide range of health metrics, from heart... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more